Differential response of human melanoma and Ehrlich ascites cells in vitro to the ribosome-inactivating protein luffin

Melanoma Research

Volumn 8, Issue 5, 1998, Pages 465-467

  Poma, A ^a   Miranda, M ^a   Spano L ^a  

^a Department of Architecture and Planning Faculty of Engineering   (Italy)

Author keywords

Antiproliferative activity; DNA fragmentation; Ehrlich ascites turnout cells; Luffin; Metastatic human melanoma cell lines; Ribosome inactivating proteins

Indexed keywords

ANTINEOPLASTIC AGENT; LUFFIN; RIBOSOME INACTIVATING PROTEIN; UNCLASSIFIED DRUG;

ANIMAL CELL; ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; CYTOTOXICITY; DRUG PURIFICATION; EHRLICH ASCITES TUMOR; HUMAN; HUMAN CELL; MELANOMA; MOUSE; NONHUMAN; PLANT SEED; PRIORITY JOURNAL; RIBOSOME;

LUFFA AEGYPTIACA;

EID: 0031773448     PISSN: 09608931     EISSN: None     Source Type: Journal    
DOI: 10.1097/00008390-199810000-00012     Document Type: Article

References (17)

1. Barbieri L, Battelli MG, Stirpe F. Ribosome-inactivating proteins from plants. Biochim Biophys Acta 1993; 1154: 237-282.
2. Barbieri L, Gorini P, Valhonesi P, et al. Unexpected activity of saporins. Nature 1994; 372: 62.
3. Spitler LE, del Rio M, Khentigan A, et al. Therapy of patients with malignant melanoma using a monoclonal antimelanoma antibody-ricin A chain immunotoxin. Cancer Res 1987; 47: 1717-1723.
4. Siegall CB, Gawlak SL, Chace D, et al. Characterization of ribosome-inactivating proteins isolated from Bryonia dioica and their utility as carcinoma-reactive immunoconjugates. Bioconjug Chem 1994; 5: 423-429.
5. French RR, Hamblin TJ, Bell AJ, et al. Treatment of B-cell lymphomas with combination of specific antibodies and saporin. Lancet 1995; 346: 223-222.
6. Tecce R, Nicotra MR, Fraiali R, et al. Saporin 6 conjugated to molecular antibody selectively kills human melanoma cells. Melanoma Res 1991; 1: 115-123.
7. Monti D, Campomori A, Capri M, et al. Abstracts of the International Conference on Cell Death in Human Pathology, Lecce (Italy), 1995: 94.
8. Williams JM, Lea N, Lord JM, et al. Comparison of ribosome-inactivating proteins in the induction of apoptosis. Toxicol Lett 1997; 91(2): 121-127.
9. Bergamaschi G, Perfetti V, Tonon, et al. Saporin, a ribosome inactivating protein used to prepare immunotoxins, induces cell death via apoptosis. Br J Haematol 1996; 93: 789-794.
10. Poma A, Galeota K, Miranda M, et al. A rihosome-inactivating protein principle from 'hairy roots and seeds of Luffa cylindrica (L) and its cytotoxicity on melanotic and amelanotic melanoma cell lines. Int Pharmacognosy 1997; 35(3): 212-214.
11. Marcozzi G, Spanò L. A simple method for the purification of type 1 RIPs. Biomed Chromatogr 1991; 11: 151-153.
12. Benhammouda A, Auclerc G, Coeffic, et al. Chemotherapy and immunotherapy of metastatic malignant melanomas. Presse Med 1996; 25(35): 1690-1697.
13. Lee SM, Betticher DC, Thatcher N. Melanoma: chemotherapy. Br Med Bull 1995; 51(3): 609-630.
14. Gasperi Campani T, Musa AR, Roncuzzi L. Diverse activity of sc-RIP saporin 6 on primary and metastatic melanoma cells in vitro. Melanoma Res 1993; 3: 363-367.
15. Pawelek J. Melanoma cells. Methods Enzymol 1979; 58: 564-570.
16. Miranda M, Amicarelli F, Poma A, et al. Cyto-genotoxic species leakage within human melanoma melanosomes. Molecular-morphological correlations. Biochem Mol Biol Int 1994; 32(5): 913-922.
17. Bolognesi A, Tazzari PL, Olivieri F, et al. Induction of apoptosis by ribosome-inactivating proteins and related immunotoxins. Int J Cancer 1996; 68: 349-355.